Tetrahydrofolate synthesis pathway
Find information on thousands of medical conditions and prescription drugs.

Cotrim

Co-trimoxazole (abbreviated SXT) is a bacteriostatic antibiotic combination of trimethoprim and sulfamethoxazole, in the ratio of 1 to 5, used in the treatment of a variety of bacterial infections. The name co-trimoxazole is the International Nonproprietary Name, and has been marketed worldwide under many brand names (GlaxoSmithKline under Septrin®, Hoffmann-La Roche as Bactrim®, and by many other generic pharmaceutical manufacturers). more...

Home
Diseases
Medicines
A
B
C
Cabergoline
Caduet
Cafergot
Caffeine
Calan
Calciparine
Calcitonin
Calcitriol
Calcium folinate
Campath
Camptosar
Camptosar
Cancidas
Candesartan
Cannabinol
Capecitabine
Capoten
Captohexal
Captopril
Carbachol
Carbadox
Carbamazepine
Carbatrol
Carbenicillin
Carbidopa
Carbimazole
Carboplatin
Cardinorm
Cardiolite
Cardizem
Cardura
Carfentanil
Carisoprodol
Carnitine
Carvedilol
Casodex
Cataflam
Catapres
Cathine
Cathinone
Caverject
Ceclor
Cefacetrile
Cefaclor
Cefaclor
Cefadroxil
Cefazolin
Cefepime
Cefixime
Cefotan
Cefotaxime
Cefotetan
Cefpodoxime
Cefprozil
Ceftazidime
Ceftriaxone
Ceftriaxone
Cefuroxime
Cefuroxime
Cefzil
Celebrex
Celexa
Cellcept
Cephalexin
Cerebyx
Cerivastatin
Cerumenex
Cetirizine
Cetrimide
Chenodeoxycholic acid
Chloralose
Chlorambucil
Chloramphenicol
Chlordiazepoxide
Chlorhexidine
Chloropyramine
Chloroquine
Chloroxylenol
Chlorphenamine
Chlorpromazine
Chlorpropamide
Chlorprothixene
Chlortalidone
Chlortetracycline
Cholac
Cholybar
Choriogonadotropin alfa
Chorionic gonadotropin
Chymotrypsin
Cialis
Ciclopirox
Cicloral
Ciclosporin
Cidofovir
Ciglitazone
Cilastatin
Cilostazol
Cimehexal
Cimetidine
Cinchophen
Cinnarizine
Cipro
Ciprofloxacin
Cisapride
Cisplatin
Citalopram
Citicoline
Cladribine
Clamoxyquine
Clarinex
Clarithromycin
Claritin
Clavulanic acid
Clemastine
Clenbuterol
Climara
Clindamycin
Clioquinol
Clobazam
Clobetasol
Clofazimine
Clomhexal
Clomid
Clomifene
Clomipramine
Clonazepam
Clonidine
Clopidogrel
Clotrimazole
Cloxacillin
Clozapine
Clozaril
Cocarboxylase
Cogentin
Colistin
Colyte
Combivent
Commit
Compazine
Concerta
Copaxone
Cordarone
Coreg
Corgard
Corticotropin
Cortisone
Cotinine
Cotrim
Coumadin
Cozaar
Crestor
Crospovidone
Cuprimine
Cyanocobalamin
Cyclessa
Cyclizine
Cyclobenzaprine
Cyclopentolate
Cyclophosphamide
Cyclopropane
Cylert
Cyproterone
Cystagon
Cysteine
Cytarabine
Cytotec
Cytovene
Isotretinoin
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Synergistic action

Co-trimoxazole exhibits a synergistic antibacterial effect when compared to each of its components administered singly. This is because trimethoprim and sulfamethoxazole inhibit successive steps in the folate synthesis pathway (see diagram below).

Sulfamethoxazole acts as a false-substrate inhibitor of dihydropteroate reductase. Sulfonamides such as sulfamethoxazole are analogues of p-aminobenzoic acid (PABA) and are competitive inhibitors of the enzyme; inhibiting the production of dihydropteroic acid.

Trimethoprim acts by interfering with the action of bacterial dihydrofolate reductase, inhibiting synthesis of tetrahydrofolic acid.

Folic acid is an essential precursor in the de novo synthesis of the DNA nucleosides thymidine and uridine. Bacteria are unable to take up folic acid from the environment (i.e. the infection host) thus are dependent on their own de novo synthesis - inhibition of the enzyme starves the bacteria of two bases necessary for DNA replication and transcription.

Clinical indications

Co-trimoxazole is more effective than either of its components individually in treating bacterial infections. However the degree of benefit for the additonal of the Sulfonamide, was in most cases marginal, but reponsible for its high association will allergic responses (see below). Its widespread use has been restricted in many countries to very specific circumstances where its improved efficacy is demonstrated. It may be effective in a variety of upper and lower respiratory tract infections, renal and urinary tract infections, gastrointestinal tract infections, skin and wound infections, septicaemias and other infections caused by sensitive organisms.

Specific indications for its use include: (Rossi, 2004)

  • treatment and prophylaxis of pneumonia caused by Pneumocystis jiroveci (P. carinii)
  • infections caused by Listeria monocytogenes, Nocardia spp., Stenotrophomonas maltophilia (Zanthomonas maltophilia)
  • melioidosis
  • shigellosis
  • traveller's diarrhoea
  • prophylaxis of cerebral toxoplasmosis in HIV patients
  • Whipple's disease

Safety

There has been some concern about its use, however, since it has been associated with both frequent mild allergic reactions and rare but serious adverse effects including Stevens-Johnson syndrome, myelosuppression, agranulocytosis, as well as severe liver damage (cholostatic hepatosis, hepatitis, liver necrosis, fulminant liver failure) and renal impairment up to acute renal failure and anuria. These side-effects are seen especially in the elderly and may be fatal. (Joint Formulary Committee, 2004)

Read more at Wikipedia.org


[List your site here Free!]


Stop UTIs in their tracts
From Nursing, 6/1/03 by Arbique, Judy C

hospitalnursing

* Nutrition for acutely ill patients

* Dehydration on the job

Learn who's at risk and how to prevent these painful infections.

For bacteria, an indwelling urethral catheter is like a red carpet to the urinary tract. Any invasive device placed in the bladder gives urinary pathogens (uropathogens) a direct route in, making the patient highly susceptible to urinary tract infections (UTIs).

Catheterized and other susceptible patients develop UTIs when uropathogens ascend and inflame the urethra or bladder in the lower urinary tract or the ureters or kidneys in the upper urinary tract. Besides causing painful symptoms, UTIs can lead to serious complications, such as renal scarring and bacteremia, and extend the patient's length of stay.

In this article, I'll describe types of UTIs, patients who are particularly susceptible, and ways to prevent or treat UTIs in your patients.

Identifying susceptible patients

Patients with indwelling urethral catheters aren't the only ones susceptible to UTIs. Because women have a shorter urethra and more bacteria near their urethral opening, they're more susceptible than men. Sexual activity, diaphragm use, and menopause each creates conditions conducive to UTI development in women.

Men under age 60 are less likely to get UTIs, but the risk increases after age 60 as the incidence of prostatitis increases.

Patients with chronic prostatitis, chronic pyelonephritis, or infected bladder stones are also susceptible to developing UTIs because these conditions constantly supply uropathogens to the urinary tract. Patients who are immunocompromised or have diabetes are susceptible too because their bodies may lack the ability to fight off ascending uropathogens.

Free-flowing and uncomplicated

A UTI is considered either uncomplicated or complicated, depending on its cause, signs, and symptoms. Uncomplicated UTIs, common in women of reproductive age who are sexually active, usually involve the lower urinary tract and occur in patients with normal urinary tract structure. Generally, bacteria from the perineum, periurethral area, vagina, or lower gastrointestinal tract infect the urethra (urethritis), the bladder (cystitis), or the upper urinary tract.

A patient with an uncomplicated lower UTI typically complains of dysuria and urinary frequency and urgency; however, she likely won't have a fever or systemic symptoms. About 20% of women with an uncomplicated UTI have suprapubic tenderness and pain. Signs and symptoms such as fever, nausea and vomiting, abdominal pain, and costovertebral-angle tenderness are more likely to occur in a patient with pyelonephritis. If your patient is symptomatic, the health care provider will order a routine urinalysis and possibly a urine culture to support a diagnosis of UTI.

* Routine urinalysis requires a clean-catch urine specimen. If the results are positive for nitrites (which indicates bacteriuria), leukocyte esterase (associated with pyuria), or protein (associated with presence of protein-containing substances such as white blood cells, mucus, and bacteria), a urine culture is necessary.

* A urine culture can identify causative pathogens, which commonly include Escherichia coli or Staphylococcus saprophyticus in uncomplicated UTI. Instructing your patient on the proper way to collect the specimen is essential to prevent contamination (see Collecting a Urine Culture Specimen and Interpreting Test Results).

Complicated, recurrent and resistant

Difficult to resolve and likely to recur, a complicated UTI usually involves the upper urinary tract and may involve the bloodstream. Complicated UTIs commonly occur in patients with urinary tract abnormalities such as bladder stones, prostatitis, strictures, tumors, neurogenic disorders, bladder diverticula, and vesicoureteral reflux. These abnormalities contribute to urinary retention and stagnation, increasing the risk of a complicated UTI.

Usually affecting middle-aged and older men and women, a complicated UTI is more likely than uncomplicated UTI to involve antibiotic-resistant microorganisms. The usual suspects include Enterococcus faecalis, Staphylococcus aureus, and species of Klebsiella, Proteus, Enterobacter, Pseudomonas, and Serratia.

A patient with an upper UTI may have pyuria, fever, chills, suprapubic pain, and costovertebral tendemess. He may also have an increased white blood cell count and proteinuria.

A complicated UTI may be a recurrence or a reinfection. Recurrent lower or upper infection caused by the original pathogen occurs within 2 weeks of completing antibiotic therapy. Reinfection caused by the original or a different pathogen occurs 2 weeks or more after completing antibiotic therapy The health care provider should further evaluate a patient with a reinfection or a recurrent infection, paying particular attention to underlying causes.

Coming from the catheter

Uropathogens can easily make their way up a urethral catheter and into the urinary tract system. Although most patients with a catheter-related UTI are asymptomatic, fever and signs of sepsis may signal infection.

Complications of UTI due to short-term catheterization include fever, acute pyelonephritis, bacteremia, and rarely, death. In older adults, confusion or

changes in alertness may be the first sign of a UTI. Complications from long-term catheterization include catheter obstruction, bladder stones, local periurethral infection, chronic renal inflammation, chronic pyelonephritis, bladder cancer, renal failure, and the same complications as from short-term catheterization.

To reduce the incidence of UTIs and their complications in catheterized patients, wash your hands with water and a conventional antiseptic-containing soap or use an alcohol-based gel or foam before and after donning gloves to care for your patients catheter. Keep the catheter drainage system closed and remove the catheter as soon as possible.

Treating a UTI in a catheterized patient includes removing or replacing the catheter and administering an antibiotic based on urine culture results.

For asymptomatic bacteriuria (colonization of bacteria in the urine), antibiotics are indicated only if your patient is pregnant, has had a kidney transplant, or is about to have urinary tract surgery.

Hampering hospital patients

Outbreaks of nosocomial infection in hospitals often involve patients with UTIs. Some 40% of nosocomial infections are UTIs, and up to 80% of these are from urinary catheterization.

Factors that increase a hospital patients risk of developing a UTI include being female or older than age 60 or having severe underlying disease, fecal incontinence, or an indwelling urethral catheter. Manipulating the catheter during diagnostic or therapeutic procedures also encourages UTI development. You can help prevent UTIs in the hospital by consistently following hand hygiene recommendations and avoiding the use of urinary catheters.

Links to long-term care

Because of increased use of catheterization, decreased fluid intake, incontinence, and changes in personal hygiene, long-term-care residents are especially susceptible to UTIs. In this population, UTIs are the most common cause of infection. In elderly long-term-care residents, UTIs are the most common cause of bacteremia. You can help protect residents from UTIs with appropriate nursing interventions (see Preventing UTIs in Long-Term Care).

Catheter-related UTIs are the most common acquired infection in long-term-care residents. If a resident becomes confused, agitated, lethargic, incontinent, or has more falls, he may have a UTI; however, these nonspecific signs can indicate other conditions too, such as dehydration.

Antibiotic therapy should be initiated in a resident who doesn't have an indwelling catheter but has acute dysuria or a temperature greater than 100 deg F (37.9 deg C) and at least one of the following criteria:

* new or worsening urinary frequency or urgency, suprapubic pain, or incontinence

* new costovertebral-angle tenderness

* gross hematuria.

Antibiotic therapy should be initiated in a resident who has an indwelling catheter and at least one of the following criteria:

* temperature greater than 1000 F

* chills

* new costovertebral-angle tenderness

* new onset of delirium.

Antibiotics shouldn't be initiated in a resident simply because his urine is cloudy or smells foul. Someone with asymptomatic bacteriuria shouldn't receive antibiotics.

A urinalysis to measure bacteria levels, nitrites, white blood cells, and leukocyte esterase aren't reliable indicators of UTI in asymptomatic residents. One study found that 50% of women and 40% of men in long-term care had significant amounts of bacteria in their urine (colonization), but didn't have a UTI.

Choosing the right treatment

To treat a UTI, the health care provider will prescribe an antibiotic specific for the uropathogen identified by the urine culture. Until culture results are available, however, an antibiotic is chosen based on local susceptibility patterns. Common antibiotic choices for treating UTIs include trimethoprim/ sulfamethoxazole (Bactrim, Septra, Cotrim), nitrofurantoin (Macrodantin, Furadantin), amoxicillin, ampicillin, and fluoroquinolones. Nitrofurantoin shouldn't be used in patients with renal insufficiency, and ciprofloxacin should be used when resistant microorganisms are present. Duration of treatment depends on the microorganism, the patient's age and sex, and whether the infection is uncomplicated or complicated.

Teach your patient to take an active role in prevention by informing her of everyday choices that can help her and her family avoid these painful infections in the future (see Teaching Your Patients to Prevent UTIs).

The power of prevention

By following hand hygiene recommendations, knowing which patients are susceptible, and recognizing signs and symptoms, you can help patients avoid UTIs, regardless of your practice setting.

SELECTED REFERENCES

Dwyer, P: "Recurrent Urinary Tract Infection in the Female," Current Opinion in Obstetrics & Gynecology. 14(5):537-543, October 2002. Kaufman, J.: "Clinical Diagnosis of Urinary Tract Infection," JAMA. 288(10):1229-1230, September 2002.

Larcombe, J.: "Urinary Tract Infection," Clinical Evidence. 12(8):406-420, December 2002.

Nicolle, L.: "Urinary Tract Infections in Long-Term-Care Facilities," Infection Control and Hospital Epidemiology. 22(3):167-175, March 2001.

Ronald, A.: "The Etiology of Urinary Tract Infection: Traditional and Emerging Pathogens," Disease-A-Month. 49(2):71-82, February 2003.

Schaeffer, A.: "Short Compared with Standard Duration of Antibiotic Treatment for Urinary Tract Infection: A Systematic Review of Randomised Controlled Trials," The Journal of Urology. 169(4):1614-1615, April 2003.

BY JUDY C. ARBIQUE, ART(CSMLS), CLS(NCA)

Judy C. Arbique is a laboratory technologist in the division of microbiology, Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada, and a partner in Arbique-Rendell Onsite Training and Consulting.

Copyright Springhouse Corporation Jun 2003
Provided by ProQuest Information and Learning Company. All rights Reserved

Return to Cotrim
Home Contact Resources Exchange Links ebay